INTRODUCTION

66
After dietary fat intake, the increase of plasma triglycerides (TG) is a normal metabolic 69), a region well-known for regulating lipid metabolism (19) . Early studies using genetically 78 engineered mouse models revealed apoA-V to be a potent modulator of plasma TG. Knocking In 2001, apoA-V was also discovered to be a novel factor significantly upregulated apoA-V to mice also dose-dependently reduced postprandial TG response (49). Authors of these 114 studies concluded that since apoA-V was only expressed in the liver, the decrease in response 115 was unlikely a result from reduced absorption but due to increased clearance of lipoproteins.
116
However, what has not been investigated thus far is the critical question: does apoA-V play a 117 role in the absorption of dietary lipids by the gut?
118
The present study was designed to examine the effects of apoA-V deficiency on the 
MATERIALS AND METHODS
138
Animals.
139
ApoA-V KO mice used in this study were backcrossed to a C57BL6/J background for at least 8 were allowed to recover for at least 24 h in Bollman restraining cages that were maintained at a Collection of intestinal tissues and luminal contents.
184
At the end of the 6 h study, mice were anesthetized in preparation for tissue and organ and intestinal tissues were taken for determination of radioactivity by scintillation spectroscopy.
193
Lipids recovered from the intestinal lumen and mucosa at the end of the study allows for analysis
194
of steady-state accumulation of lipids that are not secreted (1).
196
Absorptive and Lymphatic Transport Index Calculations.
197
To determine how efficiently the enterocyte absorbs and transports lipids into the lymph,
198
absorptive and lymphatic transport indexes were computed as previously described (7). The 
Measurement of lymphatic outputs of apoB and apoA-IV
221
The lymphatic output of apo B and apo A-IV were measured by Western blotting.
222
Samples equivalent to 3-seconds of lymph flow were resolved on 4-15% polyacrylamide Lymph flow was maintained at 0.2 -0.3 ml/h by setting the intraduodenal infusion rate at 243 0.3 ml/h ( Figure 1 ). There were no significant differences between the two groups except at the 244 5 th and 6 th hour, where the lymph flow of the WT mice decreased to 0.11 -0.12 ml/h. It should 245 be noted that this decrease occurred after steady-state has been achieved and does not affect our 246 analyses of lymphatic output of lipid (68).
247
The amount of TG transported into the lymph per hour was measured by 3 H and 248 expressed as a percentage of the hourly infused dose (Figure 2a) . Interestingly, apoA-V KO mice 249 showed substantially higher lymphatic 3 H transport at the steady-state, (52.9 ± 3.3%) than WT 250 11 controls (30.2 ± 1.5%), with differences seen as early as one hour after the start of lipid infusion.
251
Steady-state was achieved within 3 -4 h for both groups of animals.
252
The amount of cholesterol transported into the lymph was measured by cecum showing that the infused lipids were minimally excreted during our 6 h study. Overall, the 299 data suggest that the apoA-V KO mice were more efficient in taking up the TG and cholesterol 300 presented in the intestinal lumen and secreting them in the lymph.
301
To numerically represent the efficiency of the intestine to take up lipid and to transport 302 the absorbed lipid into the lymph, two indices were calculated and shown in into the lymphatics. Figure 5 shows the chylomicron appearance time is significantly (P < 0.05)
315
shorter in apoA-V KO mice (21.5 ± 3.3 min) than in WT mice (32.8 ± 2.1 min), further 316 demonstrating that apoA-V KO mice are faster at generating chylomicrons.
318
Lymphatic Output of ApoB and A-IV
319
Since the data thus far suggested that chylomicron production is enhanced in apoA-V KO 320 mice, we measured the lymphatic output of apoB, which represented the number of 321 chylomicrons produced over time, since only one apoB protein is assumed to be one 322 chylomicrons particle (2). While WT mice had a constant lymphatic output of apoB as expected,
323
apoA-V KO mice showed a steady increase in the lymphatic output of apoB (Figures 6a, b) ,
324
suggesting a greater number of chylomicrons particles produced over time. Since apoA-IV is 325 presumed to facilitate the assembly of chylomicrons (73), we also measured the lymphatic output 326 of apoA-IV. There was no difference between the two groups in the lymphatic output of apoA-
327
IV relative to fasting ( Figure 6c ) although both groups displayed a ~1.5 fold increase over 6 h,
328
which is comparable to previous studies (22, 28) . This suggests that apoA-V does not affect the The present studies demonstrate a novel role for apoA-V in the absorption of dietary lipids and 
356
The lymph cannulation method allows us to examine chylomicrons before entering the 357 circulation, which dissociates chylomicron production from clearance. A previous study by The results of this study demonstrate that apoA-V deficiency enhances the efficiency of (Table 1 ). This effect is seen specifically in the proximal 378 sections of the small intestine (Figure 3a) . Because more TG is transported as chylomicrons in 379 the apoA-V KO mice, more cholesterol is presumed to be transported out of the small intestine.
380
We find that the transport of 14 C-cholesterol from lumen to lymph is indeed enhanced in apoA-V 381 KO mice (Figures 2b and 4b) , indicating the effect of apoA-V deficiency was not specific to TG. (c.56C>G) also showed higher postprandial response after a fat load test (40). However, the 412 mechanisms underlying these effects were not further explored and were thought to be caused by 413 slower TG hydrolysis and removal of remnant lipoproteins based on evidence in mouse models.
414
Our studies direct attention to a major contribution by the gut in the delivery of chylomicron 
